
Introduction Section 1: Fundamentals of HPLC Section 2: Basics of Mass Spectrometry (MS) Section 3: Routine Applications of HPLC Section
Introduction Section 1: Fundamentals of HPLC Section 2: Basics of Mass Spectrometry (MS) Section 3: Routine Applications of HPLC Section
Introduction: In the rapidly advancing field of medicine, researchers are increasingly intrigued by proteins and peptides. As vital signaling molecules
Continue readingCustom Peptide Library Synthesis: Unraveling a Crucial Element in Modern Medicine
Introduction: In the rapidly evolving landscape of life sciences and biomedical research, the demand for customized biomolecules has surged, with
Continue readingCustom Peptide Synthesis: Tailoring Biomolecules for Scientific Advancements
Introduction: The realm of drug discovery is intrinsically linked to the precision and depth provided by analytical chemistry. In this
Introduction: In the dynamic landscape of pharmaceutical research, the pursuit of novel therapeutic agents remains a paramount objective. The intricate
Medicinal chemistry stands at the forefront of drug discovery, playing a pivotal role in the design, synthesis, and optimization of
Continue readingExploring the Frontier of Drug Discovery: The Role of Medicinal Chemistry
Introduction: In the realm of drug discovery, understanding the pharmacokinetic (PK) and pharmacodynamic (PD) properties of a compound is crucial
Part1 Financing/BD Event December 2023 November 2023 September 2023 August 2023 June 2023 May 2023 Annual Highlights of Blockbuster Products
Drug discovery and pharmacology research stand at the forefront of scientific endeavors, shaping the future of healthcare. This article delves
Continue readingUnveiling the Dynamics of Drug Discovery and Pharmacology Research
The Anhui Provincial Peptide Drug Engineering Laboratory (University of Science and Technology of China), in collaboration with a team from
On December 8th, the U.S. Food and Drug Administration (FDA) approved two groundbreaking therapeutic drugs, Casgevy (developed jointly by Vertex
Continue readingCasgevy and Lyfgenia – why they are milestones and why they are just milestones
The handling of the ends of a peptide, specifically whether to keep them free or block them, depends on the
Continue readingHow should the ends of the peptide be handled? Keep it free or block it?